Xeomin (incobotulinumtoxinA) has been approved by the U.S. Food and Drug Administration to treat chronic sialorrhea, or excessive drooling, a condition often experienced by people with cerebral palsy. Merz Neurosciences, a division of Merz North America, announced that its supplemental biologics license application (sLBA)…
Rehabilitation therapy focused on controlling and managing involuntary movements of the hands may be beneficial for some patients with a type of cerebral palsy where only one side of the body is affected, according to researchers. Their study, “Learning to cope with mirror movements in unilateral…
Infants at high risk of developing cerebral palsy have delayed development of posture control and may benefit from early postural training, a study has found. The study also suggests that children who develop cerebral palsy due to a specific type of brain lesion may benefit from different postural interventions that…
Tracking eye movement can be a viable approach to assessing language perception in children with normal development and those with neurodevelopmental delay. The study, “Using Eye Tracking (ET) as a Tool to Assess Receptive Language (RL) in Typically Developing (TD) Children and Children at High Risk for Neurodevelopmental Delay (NDD),”…
Children with cerebral palsy may benefit significantly over the long-term from intensive physical training that prevents deterioration of their motor skills. The study with that finding, “Factors Associated with Enhanced Gross Motor Progress in Children with Cerebral Palsy: A Register-Based Study,” was published recently in the journal…
A single injection of Dysport (abobotulinumtoxinA) is safe and effective in treating lower limb spasticity due to cerebral palsy in children across different age groups, according to a pooled analysis from four clinical trials. Ipsen Biopharmaceuticals presented these results during the 2018 Annual Meeting of the…
People with cerebral palsy generally are happy and satisfied with their lives despite the daily challenges they face, a recent study in Greece concluded. The study, “Sense of Coherence in People with Cerebral Palsy in Greece,” was published in the journal Psychology. Increasing evidence suggests that children…
Magnesium sulfate given to pregnant women may not prevent the incidence of cerebral palsy, but may reduce its severity, according to data from two U.S. clinical sites. The findings, “Comparison of Cerebral Palsy Severity Between 2 Eras of Antenatal Magnesium Use,” were published in JAMA Pediatrics. In the last…
A new handbook to help clinicians determine the best strategies to treat developmentally challenged children who have swallowing problems was developed by a team at Holland Bloorview Kids Rehabilitation Hospital. The handbook, “Optimizing Feeding and Swallowing in Children with Physical and Developmental Disabilities: A Practical Guide…
Pediapharm has been making its treatment for drooling available to Canadian children and adolescents with cerebral palsy and other neurological conditions. Health Canada opened the door to Cuvposa’s (glycopyrrolate’s) distribution when it approved it in November 2017. “Our sales force has been trained and is eager to communicate with health care…